Evidence map›Paper›PMID 40640494›Full record

ArticleBritish journal of cancer2025

A study of subjective memory impairment in long-term testicular cancer survivors.

Alv A Dahl, Sophie D Fosså

Abstract read
In one paragraph

Article in British journal of cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alv A DahlDepartment of Oncology, Oslo University Hospital, Oslo, Norway. alvandreas@msn.com.ORCID http://orcid.org/0000-0002-6849-2756
Sophie D FossåDepartment of Oncology, Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0002-3729-2217

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMemory impairment is a common late adverse effect in survivors of many cancer types, but there are few studies of long-term survivors of testicular cancer (LTCSs). The aims of this study were to examine memory impairment in LTCSs both longitudinally and cross-sectionally, and to compare the cross-sectional findings with normative data.

methodsA national sample of 753 LTCSs filled in questionnaires at means of 12 and 28 years after diagnosis. Memory impairment was reported by the Meta-Memory Questionnaire at 28 years. Longitudinal and cross-sectional associations between independent variables and memory impairment were examined with linear regression analyses.

resultsAt 28 years mean memory impairment scores in LTCSs hardly differed from normative values in 10-year age groups from 40 to 79 years. Many variables were significantly associated with memory impairment in univariate regression analyses both cross-sectionally and longitudinally. In multivariable analyses total fatigue was significantly associated with memory impairment longitudinally, and with total fatigue and increased neuropathy cross-sectionally.

conclusionsLTCSs at 28 years since diagnosis do not have increased level of memory impairment compared to normative data. In case of memory impairment complaints in LTCSs, several risk factors should be examined and some of them are amenable to interventions.

Indexed as

Cancer SurvivorsMemory DisordersTesticular NeoplasmsAdultAgedCross-Sectional StudiesHumansLongitudinal StudiesMaleMiddle AgedSurveys and Questionnaires

Identifiers

PMID40640494
PMCPMC12405526

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.